{"id":"https://openalex.org/W7214740365","doi":"https://doi.org/10.1016/j.phrs.2026.109655","title":"Resolution of inflammation: A novel therapeutic paradigm for rheumatoid arthritis and its comorbidities","display_name":"Resolution of inflammation: A novel therapeutic paradigm for rheumatoid arthritis and its comorbidities","publication_year":2026,"publication_date":"2026-09-29","ids":{"openalex":"https://openalex.org/W7214740365","doi":"https://doi.org/10.1016/j.phrs.2026.109655","pmid":"https://pubmed.ncbi.nlm.nih.gov/42810630"},"language":"en","primary_location":{"id":"doi:10.1016/j.phrs.2026.109655","doi":"https://doi.org/10.1016/j.phrs.2026.109655","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2026.109655","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.phrs.2026.109655","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153510579","display_name":"Roshanak Fekri Yazdi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roshanak Fekri Yazdi","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130762210","display_name":"Sze Ian Tan","orcid":"https://orcid.org/0009-0009-6425-5911","observed_orcids":["https://orcid.org/0009-0009-6425-5911"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I4405278259","display_name":"Life Sciences Institute","ror":"https://ror.org/05gtb7e09","country_code":"SG","type":"facility","lineage":["https://openalex.org/I4405278259"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Sze Ian Tan","raw_affiliation_strings":["Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Pharmacology, Singapore; Immunology Programme and Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"],"raw_orcid":"https://orcid.org/0009-0009-6425-5911","affiliations":[{"raw_affiliation_string":"Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Pharmacology, Singapore; Immunology Programme and Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I4405278259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153439596","display_name":"Weifeng Bu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Weifeng Bu","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026212984","display_name":"BRIAN BASTO FRANCO","orcid":"https://orcid.org/0009-0005-1782-1942","observed_orcids":["https://orcid.org/0009-0005-1782-1942"]},"institutions":[{"id":"https://openalex.org/I98461037","display_name":"Tecnol\u00f3gico de Monterrey","ror":"https://ror.org/03ayjn504","country_code":"MX","type":"education","lineage":["https://openalex.org/I98461037"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Brian Basto Franco","raw_affiliation_strings":["School of Engineering and Sciences, Tecnol\u00f3gico de Monterrey, N.L., Mexico"],"raw_orcid":"https://orcid.org/0009-0005-1782-1942","affiliations":[{"raw_affiliation_string":"School of Engineering and Sciences, Tecnol\u00f3gico de Monterrey, N.L., Mexico","institution_ids":["https://openalex.org/I98461037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153513204","display_name":"Ashton Juin Kai Ng","orcid":"https://orcid.org/0009-0001-8891-1356","observed_orcids":["https://orcid.org/0009-0001-8891-1356"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I4405278259","display_name":"Life Sciences Institute","ror":"https://ror.org/05gtb7e09","country_code":"SG","type":"facility","lineage":["https://openalex.org/I4405278259"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Ashton Juin Kai Ng","raw_affiliation_strings":["Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Pharmacology, Singapore; Immunology Programme and Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"],"raw_orcid":"https://orcid.org/0009-0001-8891-1356","affiliations":[{"raw_affiliation_string":"Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Pharmacology, Singapore; Immunology Programme and Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I4405278259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037070308","display_name":"Hong Yong Peh","orcid":"https://orcid.org/0000-0001-6098-9381","observed_orcids":["https://orcid.org/0000-0001-6098-9381"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I4405278259","display_name":"Life Sciences Institute","ror":"https://ror.org/05gtb7e09","country_code":"SG","type":"facility","lineage":["https://openalex.org/I4405278259"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Hong Yong Peh","raw_affiliation_strings":["Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Pharmacology, Singapore; Immunology Programme and Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: hypeh@nus.edu.sg"],"raw_orcid":"https://orcid.org/0000-0001-6098-9381","affiliations":[{"raw_affiliation_string":"Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Pharmacology, Singapore; Immunology Programme and Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: hypeh@nus.edu.sg","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I4405278259"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100665521","display_name":"Jianmin Chen","orcid":"https://orcid.org/0000-0003-0098-0857","observed_orcids":["https://orcid.org/0000-0003-0098-0857"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jianmin Chen","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom. Electronic address: jianmin.chen@qmul.ac.uk"],"raw_orcid":"https://orcid.org/0000-0003-0098-0857","affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom. Electronic address: jianmin.chen@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5100665521"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"],"apc_list":{"value":4130,"currency":"USD","value_usd":4130},"apc_paid":{"value":4130,"currency":"USD","value_usd":4130},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.57441992,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"233","issue":null,"first_page":"109655","last_page":"109655"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.34769999980926514,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.03020000085234642,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.949999988079071},{"id":"https://openalex.org/keywords/resolution-of-inflammation","display_name":"inflammation resolution","score":0.9319999814033508},{"id":"https://openalex.org/keywords/specialized-pro-resolving-mediators","display_name":"specialized pro-resolving mediators","score":0.9860000014305115},{"id":"https://openalex.org/keywords/annexin-a1","display_name":"annexin A1","score":0.9629999995231628},{"id":"https://openalex.org/keywords/melanocortin-receptors","display_name":"melanocortin receptors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/formyl-peptide-receptor-2","display_name":"formyl peptide receptor 2","score":0.968999981880188},{"id":"https://openalex.org/keywords/biased-agonism","display_name":"biased agonism","score":0.9409999847412109},{"id":"https://openalex.org/keywords/disease-modifying-antirheumatic-drugs","display_name":"disease-modifying antirheumatic drugs","score":0.8579999804496765},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7580000162124634},{"id":"https://openalex.org/keywords/synovitis","display_name":"synovitis","score":0.8259999752044678},{"id":"https://openalex.org/keywords/lipoxin-a4","display_name":"lipoxin A4","score":0.9150000214576721},{"id":"https://openalex.org/keywords/resolvins","display_name":"resolvins","score":0.9279999732971191},{"id":"https://openalex.org/keywords/maresin-1","display_name":"maresin 1","score":0.9319999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8008999824523926},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7272999882698059},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5576000213623047},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4945000112056732},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.46869999170303345},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.46869999170303345},{"id":"https://openalex.org/C68246026","wikidata":"https://www.wikidata.org/wiki/Q14908222","display_name":"Annexin A1","level":4,"score":0.46630001068115234},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4587000012397766},{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.4521999955177307},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.3736000061035156},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3711000084877014},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35409998893737793},{"id":"https://openalex.org/C2776821229","wikidata":"https://www.wikidata.org/wiki/Q16965166","display_name":"Inflammatory arthritis","level":3,"score":0.34130001068115234},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3199999928474426},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.31529998779296875},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3125},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.30250000953674316},{"id":"https://openalex.org/C2908564923","wikidata":"https://www.wikidata.org/wiki/Q810254","display_name":"Antirheumatic drugs","level":4,"score":0.2921999990940094},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.2838999927043915},{"id":"https://openalex.org/C2776252253","wikidata":"https://www.wikidata.org/wiki/Q7663815","display_name":"Systemic inflammation","level":3,"score":0.2669999897480011},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2506999969482422}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.phrs.2026.109655","doi":"https://doi.org/10.1016/j.phrs.2026.109655","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2026.109655","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},{"id":"pmid:42810630","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42810630","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological research","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05787763v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-05787763","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacological Research, 2026, 233, pp.109655. ⟨10.1016/j.phrs.2026.109655⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.phrs.2026.109655","doi":"https://doi.org/10.1016/j.phrs.2026.109655","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2026.109655","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G399670327","display_name":null,"funder_award_id":"22855","funder_id":"https://openalex.org/F4320327444","funder_display_name":"Versus Arthritis"},{"id":"https://openalex.org/G9000849814","display_name":null,"funder_award_id":"NUHSRO/2025/028/Startup/04","funder_id":"https://openalex.org/F4320327250","funder_display_name":"National University Health System"},{"id":"https://openalex.org/G9000849911","display_name":null,"funder_award_id":"PHD22-100003","funder_id":"https://openalex.org/F4320320036","funder_display_name":"Heart Research UK"},{"id":"https://openalex.org/G9000850293","display_name":null,"funder_award_id":"FS/F/22/34174","funder_id":"https://openalex.org/F4320319992","funder_display_name":"British Heart Foundation"},{"id":"https://openalex.org/G9000850809","display_name":null,"funder_award_id":"NUHSRO/2025/014/T1/Seed-Sep24/04","funder_id":"https://openalex.org/F4320320751","funder_display_name":"Ministry of Education - Singapore"}],"funders":[{"id":"https://openalex.org/F4320319992","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04"},{"id":"https://openalex.org/F4320320036","display_name":"Heart Research UK","ror":"https://ror.org/04j68sw28"},{"id":"https://openalex.org/F4320320751","display_name":"Ministry of Education - Singapore","ror":"https://ror.org/01kcva023"},{"id":"https://openalex.org/F4320327250","display_name":"National University Health System","ror":"https://ror.org/05tjjsh18"},{"id":"https://openalex.org/F4320327444","display_name":"Versus Arthritis","ror":"https://ror.org/02jkpm469"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":185,"referenced_works":["https://openalex.org/W18009198","https://openalex.org/W1520032219","https://openalex.org/W1531059701","https://openalex.org/W1832132481","https://openalex.org/W1836416096","https://openalex.org/W1897081658","https://openalex.org/W1906353445","https://openalex.org/W1928713146","https://openalex.org/W1964116563","https://openalex.org/W1964381523","https://openalex.org/W1973300090","https://openalex.org/W1974226247","https://openalex.org/W1974985368","https://openalex.org/W1977911611","https://openalex.org/W1978397248","https://openalex.org/W1979875432","https://openalex.org/W1984652891","https://openalex.org/W1985820548","https://openalex.org/W1995389009","https://openalex.org/W1996079126","https://openalex.org/W2000054651","https://openalex.org/W2003342633","https://openalex.org/W2004536682","https://openalex.org/W2022676786","https://openalex.org/W2023702942","https://openalex.org/W2031153320","https://openalex.org/W2032997971","https://openalex.org/W2040894445","https://openalex.org/W2043909750","https://openalex.org/W2054386691","https://openalex.org/W2064551563","https://openalex.org/W2067835344","https://openalex.org/W2069668467","https://openalex.org/W2074780993","https://openalex.org/W2088104136","https://openalex.org/W2090609282","https://openalex.org/W2092520647","https://openalex.org/W2093120748","https://openalex.org/W2094802457","https://openalex.org/W2102410401","https://openalex.org/W2103691265","https://openalex.org/W2104823342","https://openalex.org/W2107005433","https://openalex.org/W2107371634","https://openalex.org/W2108095498","https://openalex.org/W2108481076","https://openalex.org/W2109348687","https://openalex.org/W2115067834","https://openalex.org/W2118693619","https://openalex.org/W2120906589","https://openalex.org/W2122176733","https://openalex.org/W2124494071","https://openalex.org/W2124502562","https://openalex.org/W2127809081","https://openalex.org/W2128560476","https://openalex.org/W2128864178","https://openalex.org/W2128952666","https://openalex.org/W2129842642","https://openalex.org/W2129935236","https://openalex.org/W2131896212","https://openalex.org/W2136257423","https://openalex.org/W2140249125","https://openalex.org/W2156122843","https://openalex.org/W2158356938","https://openalex.org/W2160097074","https://openalex.org/W2166493208","https://openalex.org/W2167707357","https://openalex.org/W2168650813","https://openalex.org/W2169973614","https://openalex.org/W2171619747","https://openalex.org/W2198808464","https://openalex.org/W2279007355","https://openalex.org/W2293276114","https://openalex.org/W2332809021","https://openalex.org/W2333427125","https://openalex.org/W2341561827","https://openalex.org/W2471730875","https://openalex.org/W2507972426","https://openalex.org/W2523453502","https://openalex.org/W2534752852","https://openalex.org/W2540332636","https://openalex.org/W2560381583","https://openalex.org/W2585608783","https://openalex.org/W2587567454","https://openalex.org/W2605576483","https://openalex.org/W2615584519","https://openalex.org/W2725173787","https://openalex.org/W2746123351","https://openalex.org/W2768370261","https://openalex.org/W2791707456","https://openalex.org/W2802901067","https://openalex.org/W2805428380","https://openalex.org/W2884150642","https://openalex.org/W2886363262","https://openalex.org/W2895590824","https://openalex.org/W2897027772","https://openalex.org/W2922464218","https://openalex.org/W2980566152","https://openalex.org/W2995100408","https://openalex.org/W2997017923","https://openalex.org/W3001008876","https://openalex.org/W3004610131","https://openalex.org/W3005664296","https://openalex.org/W3025626086","https://openalex.org/W3037615636","https://openalex.org/W3041812732","https://openalex.org/W3049700996","https://openalex.org/W3082082167","https://openalex.org/W3097696932","https://openalex.org/W3105644158","https://openalex.org/W3131778757","https://openalex.org/W3135572752","https://openalex.org/W3138534285","https://openalex.org/W3156383093","https://openalex.org/W3174527541","https://openalex.org/W3196221187","https://openalex.org/W3199730097","https://openalex.org/W3209980567","https://openalex.org/W3215198319","https://openalex.org/W3216098246","https://openalex.org/W4200190696","https://openalex.org/W4210529991","https://openalex.org/W4220717334","https://openalex.org/W4221043363","https://openalex.org/W4229022294","https://openalex.org/W4280647696","https://openalex.org/W4283712430","https://openalex.org/W4297038070","https://openalex.org/W4309004275","https://openalex.org/W4311681685","https://openalex.org/W4317567765","https://openalex.org/W4317717780","https://openalex.org/W4317722312","https://openalex.org/W4322629954","https://openalex.org/W4323859309","https://openalex.org/W4362722523","https://openalex.org/W4380421992","https://openalex.org/W4380684318","https://openalex.org/W4381740425","https://openalex.org/W4381952290","https://openalex.org/W4381999884","https://openalex.org/W4385273625","https://openalex.org/W4386638276","https://openalex.org/W4387024161","https://openalex.org/W4387965581","https://openalex.org/W4388263539","https://openalex.org/W4388871663","https://openalex.org/W4388939011","https://openalex.org/W4391605789","https://openalex.org/W4391909244","https://openalex.org/W4399073013","https://openalex.org/W4399714068","https://openalex.org/W4400195354","https://openalex.org/W4400557699","https://openalex.org/W4401055966","https://openalex.org/W4402415899","https://openalex.org/W4403268029","https://openalex.org/W4404488949","https://openalex.org/W4404934637","https://openalex.org/W4405194754","https://openalex.org/W4405807766","https://openalex.org/W4406192889","https://openalex.org/W4408154142","https://openalex.org/W4408478590","https://openalex.org/W4408491188","https://openalex.org/W4409117566","https://openalex.org/W4409182813","https://openalex.org/W4409469237","https://openalex.org/W4410513389","https://openalex.org/W4410700023","https://openalex.org/W4410755943","https://openalex.org/W4410971260","https://openalex.org/W4412138291","https://openalex.org/W4412592968","https://openalex.org/W4412710046","https://openalex.org/W4412956632","https://openalex.org/W4413113003","https://openalex.org/W4413487743","https://openalex.org/W4414340120","https://openalex.org/W4415041267","https://openalex.org/W4415050487","https://openalex.org/W4416252631","https://openalex.org/W7118160844","https://openalex.org/W7135041886","https://openalex.org/W7163903801"],"related_works":["https://openalex.org/W4387597660","https://openalex.org/W4388774104","https://openalex.org/W2983911933","https://openalex.org/W7211902469","https://openalex.org/W3196746148","https://openalex.org/W2734825113","https://openalex.org/W4408841650","https://openalex.org/W4297038070","https://openalex.org/W2424727367","https://openalex.org/W2910116296"],"abstract_inverted_index":{"Rheumatoid":[0],"arthritis":[1],"(RA)":[2],"is":[3,206],"a":[4,46,69,151,230],"systemic":[5,53],"immune-mediated":[6],"disease":[7,64,140],"in":[8,42,168,191],"which":[9],"persistent":[10,44],"synovial":[11],"inflammation":[12,81],"contributes":[13],"not":[14,207],"only":[15],"to":[16,21,173,208,214],"joint":[17],"destruction":[18],"but":[19,213],"also":[20],"cardiovascular,":[22],"pulmonary,":[23],"metabolic,":[24],"and":[25,51,66,82,115,129,141,163,170,177,188,220,246],"other":[26],"extra-articular":[27],"complications.":[28],"This":[29,119,180],"review":[30,120,181],"focuses":[31],"specifically":[32],"on":[33],"the":[34,75,109,122,132,200],"translational":[35,232],"potential":[36,134],"of":[37,135],"emerging":[38],"receptor-directed":[39],"pro-resolving":[40,97,101,161],"therapeutics":[41],"targeting":[43,95],"inflammation,":[45],"common":[47],"mechanism":[48],"driving":[49],"RA":[50,128,245],"its":[52,247],"comorbidities.":[54,144,248],"Although":[55],"contemporary":[56],"disease-modifying":[57],"antirheumatic":[58],"drugs":[59],"(DMARDs)":[60],"have":[61],"substantially":[62],"improved":[63],"control":[65],"structural":[67],"outcomes,":[68],"complementary":[70],"therapeutic":[71,133,153,242],"question":[72,93],"remains:":[73],"can":[74],"endogenous":[76,96],"biological":[77],"program":[78],"that":[79,199],"terminates":[80],"restores":[83],"tissue":[84,221],"homeostasis":[85],"be":[86,228],"therapeutically":[87],"engaged?":[88],"Resolution":[89],"pharmacology":[90,149,205,225],"addresses":[91],"this":[92],"by":[94],"pathways":[98],"involving":[99],"specialized":[100],"mediators":[102],"(SPMs),":[103],"annexin":[104],"A1":[105],"(AnxA1),":[106],"melanocortin":[107],"receptors,":[108],"formyl":[110],"peptide":[111],"receptor":[112,184],"2":[113],"(FPR2/ALX),":[114],"related":[116],"signalling":[117],"networks.":[118],"examines":[121],"evidence":[123,165],"linking":[124],"defective":[125],"resolution":[126,148,204,224],"with":[127,193],"critically":[130],"evaluates":[131],"resolution-directed":[136],"interventions":[137],"across":[138],"articular":[139],"major":[142],"RA-associated":[143],"Rather":[145],"than":[146,239],"treating":[147],"as":[150],"uniform":[152],"class,":[154],"we":[155],"distinguish":[156],"anti-inflammatory":[157],"effects":[158],"from":[159,167],"demonstrated":[160],"activities":[162],"evaluate":[164],"ranging":[166],"vitro":[169],"animal":[171],"studies":[172,176],"observational":[174],"human":[175],"clinical":[178,236],"trials.":[179],"particularly":[182],"emphasizes":[183],"selectivity,":[185],"biased":[186],"agonism,":[187],"their":[189],"use":[190],"combination":[192],"established":[194,241],"DMARD":[195,211],"therapies.":[196],"We":[197],"propose":[198],"principal":[201],"opportunity":[202],"for":[203,244],"replace":[209],"effective":[210],"therapy":[212],"complement":[215],"it,":[216],"promoting":[217],"inflammatory":[218],"termination":[219],"recovery.":[222],"Thus,":[223],"should":[226],"currently":[227],"considered":[229],"promising":[231],"framework":[233],"requiring":[234],"future":[235],"validation":[237],"rather":[238],"an":[240],"paradigm":[243]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2026-09-30T00:00:00"}